Section IV of Part III of the TRIPS Agreement impose certain obligations to WTO Member States relating to border measures that may require custom authorities interventions in cases of importation of infringing goods. However, as the rest of Part III it also allows considerable flexibility to WTO Members States in implementing its obligations.
May 28th, 2007 by James Love
Written by James Love
Thursday, 26 June 2008
These are the substantive suggestions for provisions of the ACTA that the RIAA sent to the USTR on March 17, 2008.
What Are Counterfeit Medicines?
The definition of a counterfeit medicine is not well established. In 1992, the WHO defined a counterfeit medicine as: “a medicine which is deliberately and fraudulently mislabelled with respect to identity and/or source." Under this definition, it is the deliberate mislabeling of a drug or medicine which makes it a counterfeit. The US FDA uses a similar definition,
To provide some context to discussions on the term of protection for copyright and related rights, the following note sumarizes on the basic provisions in various multilateral copyright and related rights treaties, on the topics of minimum terms and formalities. … Continue Reading
Written by James Love Continue Reading
Return to KEI page on prizes to stimulate innovation
A separate page on academic and other technical papers and comments on prizes is available
here:
News Reports and Blogs on Innovation Prizes
On Saturday, KEI filed comments with the WHO EWG’s 2nd web based hearing. Our comments focused on the criteria for new proposals. Continue Reading
This paper has now been replaced by an updated version here: /prizes/cites
—————
An Annotated Bibliography of Scholarly and Technical Articles and Books on Innovation Prizes
KEI Research Note 2008:2
(Updated October 4, 2010)
2010. William Fisher and Talha Syed. Drugs, Law, and the Health Crisis in the Developing World. Stanford University Press. [link] Continue Reading
PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS
KEI Research Note 2007:1
Benjamin Krohmal*
March 1, 2007